Protein Kinase Inhibitors: Current Strategies and Future ProspectsCABALLERO, Julio.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, issn 1381-6128, 145 p.Serial Issue

Kinase Inhibitor ConjugatesHARMSEN, Stefan; KOK, Robbert Jan.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2891-2900, issn 1381-6128, 10 p.Article

Exploiting Substrate Recognition for Selective Inhibition of Protein KinasesLICHT-MURAVA, Avital; ELDAR-FINKELMAN, Hagit.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2914-2920, issn 1381-6128, 7 p.Article

Radiolabeled Small Molecule Inhibitors of VEGFR - Recent AdvancesKNIESS, Torsten.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2867-2874, issn 1381-6128, 8 p.Article

Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical TrialsCUNLONG ZHANG; CHUNYAN TAN; HUAIWEI DING et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2921-2935, issn 1381-6128, 15 p.Article

Cyclin-dependent kinase Inhibitors Inspired by Roscovitine: Purine BioisosteresJORDA, Radek; PARUCH, Kamil; KRYSTOF, Vladimir et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2974-2980, issn 1381-6128, 7 p.Article

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug TargetKRYSTOF, Vladimir; BAUMLI, Sonja; FÜRST, Robert et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2883-2890, issn 1381-6128, 8 p.Article

Recent Advances in Designing Substrate-Competitive Protein Kinase InhibitorsHAN, Ki-Cheol; SO YEON KIM; EUN GYEONG YANG et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2875-2882, issn 1381-6128, 8 p.Article

Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic ComplicationsHONG ZHOU; LI, Yong-Jun.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2964-2973, issn 1381-6128, 10 p.Article

Conformationally Constrained Peptides as Protein Tyrosine Kinase InhibitorsTIWARI, Rakesh K; PARANG, Keykavous.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2852-2866, issn 1381-6128, 15 p.Article

New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent InhibitorsLAMBA, Vandana; GHOSH, Indraneel.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2936-2945, issn 1381-6128, 10 p.Article

Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential ApplicationsPRIEGO, Eva-Maria; KARLSSON, Anna; GAGO, Federico et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2981-2994, issn 1381-6128, 14 p.Article

Molecular Dynamics of Protein Kinase-Inhibitor Complexes: A Valid Structural InformationCABALLERO, Julio; ALZATE-MORALES, Jans H.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2946-2963, issn 1381-6128, 18 p.Article

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and PerspectivesMENGZHU XUE; XIANWEN CAO; YE ZHONG et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2901-2913, issn 1381-6128, 13 p.Article